Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > My thanks , philosophical thoughts

<< Previous

Bullboard Posts

Next >>

Comment by venture009on Nov 23, 2024 10:36am

51 Views

Post# 36327361

RE:RE:RE:RE:My thanks , philosophical thoughts

Quentin, I think March is too long a time frame. The economics of the US and global economies are in dire straits. It is going to get more and more difficult to get companies to part with their money with the looming financial disaster. They need to secure something by year end.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments